C-Bridge Capital

C-Bridge Capital Partners identifies and unlocks opportunities to drive growth and development across borders. They leverage their expertise in the United States, China and Israel to help their global clients form international strategic alliances that achieve maximum returns. Using their unparalleled network and extensive knowledge, They facilitate cross-border investments and asset formation in the US, China and Israel. They remain involved to monitor and protect their clients’ investment interests.

C-Bridge Capital, established in 2014 and headquartered in New York, New York, United States, North America., specializes in Private Equity, Early Stage Venture, Late Stage Venture investments across Biotechnology, Life Science, Health Care, Therapeutics, Internet, Medical, Medical Device, Pharmaceutical, Sales, Manufacturing. The organization boasts a portfolio of 15 investments, with an average round size of $104.0M and 5 successful exits. Their recent investments include Clarus Therapeutics, Anrei Medical, Adcentrx Therapeutics, CBC Group, Hasten. The highest investment round they participated in was $136.7B. Among their most notable exits are Clarus Therapeutics and Anrei Medical. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.